Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -390,978 | -372,177 | -444,037 | -395,893 | -342,252 |
| Depreciation Amortization | 40,122 | 37,810 | 29,522 | 21,609 | 19,993 |
| Income taxes - deferred | -2,071 | -2,828 | -3,479 | N/A | N/A |
| Accounts receivable | -13,108 | -69,189 | -149 | N/A | N/A |
| Accounts payable and accrued liabilities | -6,661 | -7,841 | 4,828 | 5,883 | 6,976 |
| Other Working Capital | -24,266 | -127,021 | -6,521 | -2,892 | 24,553 |
| Other Operating Activity | 94,554 | 188,269 | 58,016 | 78,536 | 62,789 |
| Operating Cash Flow | $-302,408 | $-352,977 | $-361,820 | $-292,757 | $-227,941 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 81,332 | -32,769 | 79,681 | 276,880 | 37,706 |
| PPE Investments | -33,836 | -11,069 | -22,290 | -20,425 | -37,574 |
| Net Acquisitions | N/A | -52,573 | -212,633 | N/A | N/A |
| Investing Cash Flow | $47,496 | $-96,411 | $-155,242 | $256,455 | $132 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,000 |
| Common Stock Issued | 307,832 | 403,522 | 465,754 | 192,799 | 238,268 |
| Other Financing Activity | -7,059 | -12,858 | -2,795 | -2,649 | 0 |
| Financing Cash Flow | $300,773 | $390,664 | $462,959 | $190,150 | $239,268 |
| Exchange Rate Effect | 1,144 | -541 | -2,740 | N/A | N/A |
| Beginning Cash Position | 122,053 | 181,318 | 238,161 | 84,313 | 72,854 |
| End Cash Position | 169,058 | 122,053 | 181,318 | 238,161 | 84,313 |
| Net Cash Flow | $47,005 | $-59,265 | $-56,843 | $153,848 | $11,459 |
| Free Cash Flow | |||||
| Operating Cash Flow | -302,408 | -352,977 | -361,820 | -292,757 | -227,941 |
| Capital Expenditure | -33,836 | -11,069 | -22,290 | -20,425 | -37,574 |
| Free Cash Flow | -336,244 | -364,046 | -384,110 | -313,182 | -265,515 |